Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer | NEJM
Mismatch repair–deficient (dMMR) tumors can be found in 10 to 15% of patients with nonmetastatic colon cancer. In these patients, the efficacy of chemotherapy is limited. The use of neoadjuvant imm…